Daiichi Sankyo paid $4 billion for Ranbaxy, an Indian maker of generic drugs with strong sales in emerging markets.

• DaiichiSankyo以40亿美元购入Ranbaxy，Ranbaxy是一家研制生物医药的印度公司，在新兴市场有销售情况很不错。